Suit Claims Illumina's Sequencer Infringes DNA Amplification Patent | GenomeWeb

NEW YORK (GenomeWeb News) – A suit filed in the US District Court for the District of Delaware today claims that Illumina's Genome Analyzer and related products and services infringe a patent originally issued to Genelabs and now held by a firm called LadaTech.

According to court documents, LadaTech has accused Illumina of infringing US Patent 6,107,023, "DNA Amplification and Subtraction Techniques," which was issued in 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.